StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics cash

Cash and short-term investments held at the end of each period.

HCW Biologics's cash was $741.32K at Jun 30, 2026. For fiscal 2025 it was $1.95M, down 58.2% from the year before. The highest annual figure on record is $36.71M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.95M-58.2%
FY2024Dec 31, 2024$4.67M+30.0%
FY2023Dec 31, 2023$3.60M-88.8%
FY2022Dec 31, 2022$32.06M-12.7%
FY2021Dec 31, 2021$36.71M+334.2%
FY2020Dec 31, 2020$8.46M+15.0%
FY2019Dec 31, 2019$7.36M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$741.32K-69.6%
Q1 FY2026Mar 31, 2026$1.23M+10.9%
Q4 FY2025Dec 31, 2025$1.95M-58.2%
Q3 FY2025Sep 30, 2025$1.10M+9.9%
Q2 FY2025Jun 30, 2025$2.44M+110.0%
Q1 FY2025Mar 31, 2025$1.11M-72.9%
Q4 FY2024Dec 31, 2024$4.67M+30.0%
Q3 FY2024Sep 30, 2024$998.22K-91.1%
Q2 FY2024Jun 30, 2024$1.16M-93.3%
Q1 FY2024Mar 31, 2024$4.08M-85.5%
Q4 FY2023Dec 31, 2023$3.60M-88.8%
Q3 FY2023Sep 30, 2023$11.22M-57.2%
Q2 FY2023Jun 30, 2023$17.41M-46.3%
Q1 FY2023Mar 31, 2023$28.24M-19.5%
Q4 FY2022Dec 31, 2022$32.06M-12.7%
Q3 FY2022Sep 30, 2022$26.22M-34.6%
Q2 FY2022Jun 30, 2022$32.41M+541.8%
Q1 FY2022Mar 31, 2022$35.09M+411.8%
Q4 FY2021Dec 31, 2021$36.71M+334.2%
Q3 FY2021Sep 30, 2021$40.11M+518.8%
Q2 FY2021Jun 30, 2021$5.05M+59.4%
Q1 FY2021Mar 31, 2021$6.86M-6.8%
Q4 FY2020Dec 31, 2020$8.46M–
Q3 FY2020Sep 30, 2020$6.48M–
Q2 FY2020Jun 30, 2020$3.17M–
Q4 FY2019Dec 31, 2019$7.36M–

More HCW Biologics figures

See a number that looks wrong?